Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report

A randomized controlled study of rituximab demonstrated that the drug protects pancreatic function in patients with acute-onset type 1 diabetes mellitus (AOT1DM). However, the mechanism of this protective effect is poorly understood. We examined the effects of rituximab in two patients with AOT1DM i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Endocrinol Diabetes Metab Case Rep
Egile Nagusiak: Kurozumi, Akira, Okada, Yosuke, Arao, Tadashi, Miyazaki, Yusuke, Yoshikawa, Maiko, Torimoto, Keiichi, Kubo, Satoshi, Nakayamada, Shingo, Tanaka, Yoshiya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Bioscientifica Ltd 2016
Gaiak:
Insight into Disease Pathogenesis or Mechanism of Therapy
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4870497/
https://ncbi.nlm.nih.gov/pubmed/27252867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-16-0020
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak